Acute myeloid leukemia (AML) is an aggressive malignancy only cured by intensive therapy. However, many elderly and unfit patients cannot receive such treatment due to an unacceptable risk of treatment-related morbidity and mortality. | Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia identification of responders by gene expression profiling of pretreatment leukemic cells